The aim of this study is to assess the fitted parameters of ESWAN in ovarian tumors and to investigate their potential in distinguishing borderline from malignant epithelial ovarian tumors, which can provide detailed information for clinical treatment. R2* and T2* in ESWAN were the key parameters for distinguishing borderline from malignant epithelial ovarian tumors. MR-ESWAN sequence can be used as non-enhancement quantitative indexes, which has a good application prospect.
This abstract and the presentation materials are available to members only; a login is required.